Phytosterols (PS) as immunomodulators of Multiple Sclerosis (MS)
نویسندگان
چکیده
منابع مشابه
Immunotherapy in Multiple Sclerosis (Ms)
Summary The immunosuppressive agent has changed the clinical course of MS. Mostly,this agent, like cyclophosphamide cyclosporine A., and X-Ray of the lymphoid organ, has a lot of side effects. It should only be used in the most severe from of MS among immunosuppressive agents, Azathioprin has been used most frequently in spite of the fact that it is not very effective compared with other immun...
متن کاملPresenting the Sport Participation Model of Multiple Sclerosis (MS) Patients
Introduction: The study aims to present the sport participation model of multiple sclerosis (MS) patients. Methods: This research was exploratory mixed method (qualitative-quantitative), respectively. The population in the qualitative section of the study consisted of some sports authorities, specialist physicians, sports management professors and a number of athletes with MS illnesses (n ...
متن کاملInvestigation of Gait Initiation in Women With Multiple Sclerosis (MS)
Background: Walking impairment is one of the most reported symptoms of Multiple Sclerosis (MS). The documentation of gait impairments is important for indexing disease progression and rehabilitation in MS. By measuring and comparing relevant parameters based on the Center of Pressure (COP) patterns, this study aimed to characterize the execution of the gait task and to identify the relationship...
متن کاملPrevalence and Incidence of Multiple Sclerosis (MS) in Guilan Province
Introduction: The aim of this study was to investigate the prevalence and incidence of multiple sclerosis (MS) in Guilan Province) and to compare the standardized prevalence by the factor of age in this province. Methods: The study was a cross-sectional design that was conducted in 2018 at the Guilan MS Society (GMSS) on people with multiple sclerosis and examined the 654 people with multiple ...
متن کاملClinical predictors of response to immunomodulators for multiple sclerosis.
OBJECTIVES To determine, based on clinical criteria, the proportion of multiple sclerosis (MS) patients responsive to immunomodulators (RI) and nonresponsive to immunomodulators (NRI), and to ascertain whether clinical and epidemiological data differs between RI and NRI patient groups. METHODS Patients were assessed on rate of exarcerbations per year, for the period before and after commencem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The FASEB Journal
سال: 2010
ISSN: 0892-6638,1530-6860
DOI: 10.1096/fasebj.24.1_supplement.332.8